X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (8941) 8941
Publication (1080) 1080
Book Review (210) 210
Report (132) 132
Book Chapter (85) 85
Newspaper Article (45) 45
Magazine Article (20) 20
Book / eBook (19) 19
Newsletter (19) 19
Conference Proceeding (12) 12
Dissertation (8) 8
Reference (3) 3
Data Set (2) 2
Trade Publication Article (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
animals (4716) 4716
humans (4295) 4295
index medicus (3974) 3974
male (3411) 3411
rats (2170) 2170
female (2040) 2040
sodium (1536) 1536
pharmacology & pharmacy (1514) 1514
physiology (1466) 1466
hypertension (1392) 1392
neurosciences (1257) 1257
middle aged (1098) 1098
sodium - metabolism (938) 938
adult (901) 901
cardiac & cardiovascular systems (873) 873
rats, sprague-dawley (854) 854
aged (805) 805
blood pressure - drug effects (800) 800
hypertension - drug therapy (799) 799
mice (780) 780
blood pressure (775) 775
peripheral vascular disease (749) 749
blood-pressure (728) 728
calcium - metabolism (712) 712
dose-response relationship, drug (651) 651
in vitro techniques (648) 648
analysis (621) 621
research (565) 565
hypertension - physiopathology (557) 557
rats, wistar (551) 551
article (546) 546
antihypertensive agents - therapeutic use (543) 543
calcium (543) 543
cell biology (543) 543
rodents (531) 531
calcium channel blockers - pharmacology (529) 529
time factors (528) 528
risk factors (523) 523
biochemistry & molecular biology (516) 516
urology & nephrology (516) 516
cells, cultured (505) 505
physiological aspects (489) 489
sodium channel blockers - pharmacology (482) 482
diuretics (467) 467
calcium channel blockers - therapeutic use (465) 465
sodium channels (459) 459
medicine & public health (448) 448
neurons (438) 438
patch-clamp techniques (437) 437
clinical neurology (429) 429
drugs (428) 428
cells (421) 421
electrophysiology (421) 421
ion channels (419) 419
disease models, animal (414) 414
heart (406) 406
sodium channels - metabolism (401) 401
treatment outcome (396) 396
health aspects (393) 393
care and treatment (389) 389
rat (389) 389
potassium (383) 383
expression (376) 376
amiloride - pharmacology (368) 368
medicine (365) 365
inhibition (362) 362
proteins (361) 361
mortality (359) 359
aldosterone (350) 350
activation (348) 348
potassium - metabolism (342) 342
multidisciplinary sciences (339) 339
research article (338) 338
medicine, general & internal (337) 337
neurology (337) 337
tetrodotoxin - pharmacology (336) 336
nitric oxide (335) 335
ischemia (333) 333
brain (331) 331
drug therapy (331) 331
endocrinology & metabolism (327) 327
sodium chloride symporter inhibitors - therapeutic use (327) 327
membrane potentials - drug effects (320) 320
potassium channels (318) 318
sodium-potassium-exchanging atpase - metabolism (317) 317
mutation (310) 310
channels (309) 309
cardiology (304) 304
diabetes (301) 301
drug therapy, combination (296) 296
heart failure (296) 296
sodium-channels (294) 294
electrocardiography (291) 291
oxidative stress (290) 290
double-blind (288) 288
neurons - drug effects (288) 288
pharmacology (286) 286
toxicology (286) 286
enzyme inhibitors - pharmacology (282) 282
sodium channels - drug effects (282) 282
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (9163) 9163
German (12) 12
Japanese (11) 11
Russian (9) 9
French (8) 8
Chinese (4) 4
Spanish (4) 4
Italian (2) 2
Polish (2) 2
Portuguese (2) 2
Swedish (2) 2
Czech (1) 1
Danish (1) 1
Hungarian (1) 1
Korean (1) 1
Lithuanian (1) 1
Norwegian (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The Journal of Clinical Pharmacology, ISSN 0091-2700, 01/2019, Volume 59, Issue 1, pp. 90 - 97
Vixotrigine is a state‐ and use‐dependent Nav1.7 channel blocker being investigated for the treatment of neuropathic pain conditions. This randomized,... 
Nav1.7 | blood pressure | pain | sodium channel blocker | pharmacokinetics | adverse event | vixotrigine | state‐dependent | state-dependent | TRIGEMINAL NEURALGIA | PHARMACOLOGY & PHARMACY | Heart rate | Headache | Randomization | Pain | Sodium channels (voltage-gated) | Nausea | Blood pressure | Adults | Neuropathy | Mercury | Therapeutics
Journal Article
European Journal of Pharmacology, ISSN 0014-2999, 08/2016, Volume 784, pp. 1 - 14
Recent understanding of the systems that mediate complex disease states, has generated a search for molecules that simultaneously modulate more than one... 
Nav1.7 | NMDA | Substituted aminoquinoline | Chronic pain | GluN2B | Nav1.8 | 1.7 | 1.8 | D-ASPARTATE RECEPTORS | SPINAL-CORD | SUBUNIT EXPRESSION | DORSAL-ROOT GANGLION | ETHANOL INHIBITION | GLUTAMATE RECEPTORS | OF-HEALTH PATHWAYS | OPIOID RECEPTOR | MECHANICAL HYPERALGESIA | ELECTROPHYSIOLOGICAL PROPERTIES | PHARMACOLOGY & PHARMACY | Na(v)1.7 | Na(v)1.8 | Quinolines - blood | Cricetulus | Humans | Neuralgia - metabolism | Receptors, N-Methyl-D-Aspartate - metabolism | Male | Molecular Targeted Therapy | Quinolines - pharmacology | Brain - metabolism | Protein Isoforms - metabolism | Inflammation - drug therapy | Phenylurea Compounds - chemistry | HEK293 Cells | Anti-Inflammatory Agents - therapeutic use | Sodium Channel Blockers - therapeutic use | CHO Cells | Sodium Channel Blockers - blood | Cricetinae | Anti-Inflammatory Agents - pharmacology | Quinolines - chemistry | Phenylurea Compounds - therapeutic use | Rats | Sodium Channel Blockers - pharmacology | Phenylurea Compounds - blood | Rats, Sprague-Dawley | Neuralgia - drug therapy | Anti-Inflammatory Agents - blood | Brain - drug effects | Animals | Anti-Inflammatory Agents - chemistry | Phenylurea Compounds - pharmacology | Quinolines - therapeutic use | Sodium Channel Blockers - chemistry | Chronic Disease | Voltage-Gated Sodium Channels - metabolism | Physiological aspects | Quinoline | Cytokinins | Neurosciences | Analysis | substituted aminoquinoline
Journal Article
Journal Article
European Journal of Pharmacology, ISSN 0014-2999, 01/2015, Volume 746, pp. 213 - 220
Journal Article
Diabetes, Obesity and Metabolism, ISSN 1462-8902, 05/2016, Volume 18, Issue 5, pp. 463 - 474
Aim To report the results of two phase III trials assessing the efficacy of ranolazine for glycaemic control in patients with type 2 diabetes on metformin or... 
clinical trial | antidiabetic drug | glycaemic control | type 2 diabetes | randomized trial | Type 2 diabetes | Clinical trial | Randomized trial | Antidiabetic drug | Glycaemic control | Ranolazine - adverse effects | Ranolazine - pharmacokinetics | Metformin - therapeutic use | Ranolazine - therapeutic use | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Male | Metformin - adverse effects | Hypoglycemia - prevention & control | Glycated Hemoglobin A - antagonists & inhibitors | Hypoglycemic Agents - blood | Drug Therapy, Combination - adverse effects | Drug Interactions | Sodium Channel Blockers - adverse effects | Sodium Channel Blockers - therapeutic use | Female | Sulfonylurea Compounds - blood | Sulfonylurea Compounds - pharmacokinetics | Hypoglycemia - chemically induced | Drug Resistance | Metformin - blood | Hypoglycemic Agents - therapeutic use | Sodium Channel Blockers - blood | Hyperglycemia - prevention & control | Ranolazine - blood | Hypoglycemic Agents - pharmacokinetics | Double-Blind Method | Metformin - pharmacokinetics | Sulfonylurea Compounds - therapeutic use | Sulfonylurea Compounds - adverse effects | Diabetes Mellitus, Type 2 - blood | Aged | Cardiovascular Diseases - chemically induced | Diabetes Mellitus, Type 2 - drug therapy | Drug Monitoring | Sodium Channel Blockers - pharmacokinetics | Hypoglycemic Agents - adverse effects | Glycosylated hemoglobin | Glimepiride | Care and treatment | Diabetes therapy | Confidence intervals | Diabetes | Clinical trials | Hemoglobin | Metformin | Diabetes mellitus
Journal Article
Journal Article
Clinical Toxicology, ISSN 1556-3650, 08/2013, Volume 51, Issue 7, pp. 545 - 549
Abstract Introduction. Lamotrigine is a phenyltriazine compound that inhibits voltage-gated sodium channels, decreasing release of glutamate and aspartate, and... 
Neurotoxicity | Serotonin syndrome | Cardiotoxicity | Pharmacokinetics | Sodium channel blockade | SEROTONIN REUPTAKE INHIBITORS | AUGMENTATION | OVERDOSE | LONG QT SYNDROME | TOXICOLOGY | FORCED SWIMMING TEST | OBSESSIVE-COMPULSIVE DISORDER | Neurotransmitter Uptake Inhibitors - poisoning | Voltage-Gated Sodium Channel Blockers - pharmacokinetics | Neurotoxicity Syndromes - diagnosis | Arrhythmias, Cardiac - chemically induced | Excitatory Amino Acid Antagonists - poisoning | Neurotransmitter Uptake Inhibitors - pharmacokinetics | Voltage-Gated Sodium Channel Blockers - poisoning | Serotonin Uptake Inhibitors - poisoning | Drug Overdose | Excitatory Amino Acid Antagonists - pharmacokinetics | Humans | Middle Aged | Dopamine Uptake Inhibitors - poisoning | Child, Preschool | Infant | Male | Seizures - chemically induced | Young Adult | Neurotoxicity Syndromes - therapy | Time Factors | Suicide, Attempted | Electrocardiography | Adult | Female | Adrenergic Uptake Inhibitors - poisoning | Retrospective Studies | Voltage-Gated Sodium Channel Blockers - blood | Neurotransmitter Uptake Inhibitors - blood | Arrhythmias, Cardiac - therapy | Triazines - poisoning | Seizures - diagnosis | Triazines - blood | Pennsylvania | Excitatory Amino Acid Antagonists - blood | Neurotoxicity Syndromes - etiology | Arrhythmias, Cardiac - diagnosis | Triazines - pharmacokinetics | Complications and side effects | Research | Lamotrigine | Index Medicus | Abridged Index Medicus
Journal Article
Journal Article